Hikal, Pfizer Sign Agreement for API Supply

ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer and Hikal signed a contract manufacturing agreement in which Hikal will supply active pharmaceutical ingredients.

Mumbai, India (Jan. 7)-Pfizer (New York) and Hikal signed a contract manufacturing agreement in which Hikal will supply active pharmaceutical ingredients. Terms of the agreement were not disclosed at press time.

“We are extremely pleased to be selected as a long-term contract manufacturer by Pfizer,” said Jai Hiremath, vice chairman and managing director of Hikal in a company statement. “This agreement will have a substantial impact on our pharmaceutical business in the coming years.” 

“We look forward to working with Hikal, a respected contract manufacturing company and are delighted that they are able to contribute towards supply of APIs for Pfizer products,” said Peter Stevenson, vice-president, global contract manufacturing, procurement and Pfizer Center Source, Pfizer Inc., in a prepared statement.